PPIDT00488
Drug Information
| Name | Insulin icodec |
|---|---|
| Sequence | FVNQHLCGSHLVEALHLVCGERGFHYTPK |
| DrugBank_ID | DB16693 |
| Type | biotech |
| Indication | Insulin icodec is indicated for the once-weekly treatment of adults with diabetes mellitus in order to improve glycemic control.[L50758,L50763] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
700 U/ml
|
| Solution | Subcutaneous |
1050 unit / 1.5 mL
|
| Solution | Subcutaneous |
2100 unit / 3 mL
|
| Solution | Subcutaneous |
700 unit / mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P06213 | INSR | Insulin receptor | Homo sapiens | agonist | Link |
| target | P08069 | IGF1R | Insulin-like growth factor 1 receptor | Homo sapiens | agonist | Link |
| enzyme | P14735 | IDE | Insulin-degrading enzyme | Homo sapiens | substrate | Link |
| carrier | P02768 | ALB | Albumin | Homo sapiens | binder | Link |